Company intelligence / Profile preview

TwoStep Therapeutics

San Carlos, California, United Statestwosteptx.com ↗

Ownership: Private
Development stage: Preclinical

Overview

TwoStep Therapeutics has demonstrated in vivo proof of concept for its multi-targeted agent using various therapeutic payloads and fusion proteins in academic labs and within the Stanford Innovative Medicines Accelerator. The lead program, a tumor-targeted drug conjugate, has shown outstanding preclinical efficacy and safety. A radiopharmaceutical program is also advancing through preclinical development

Therapeutic areas: Oncology
Modalities: Peptide-drug conjugatesRadiopharmaceuticals (radioligand therapy)Immunotherapy agents (fusion proteins)
Industry: Biotech

Drug pipeline

2 assets

PIP-based tumor-targeting platform

Preclinical

1 more asset in the full pipeline.

Request access →

Partnerships

Johnson & Johnson Innovation – JLABS residency at MBC BioLabs site

Beyond the preview

Go deeper on TwoStep Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TwoStep Therapeutics.

Explore the full profile